Sunesis Pharmaceuticals, Inc. (SNSS)
Q4 2019 Results Earnings Conference Call
March 10, 2020, 4:30 pm ET
Company Participants
Willie Quinn - Chief Financial Officer, Senior Vice President, Finance and Corporate Development
Dayton Misfeldt - Interim Chief Executive Officer
Judy Fox - Chief Scientific Officer, Executive Vice President, Research & Development
Conference Call Participants
Hartaj Singh - Oppenheimer
Jim Birchenough - Wells Fargo
Marc Frahm - Cowen
Presentation
Operator
Welcome to Sunesis Pharmaceuticals fourth quarter and year-end 2019 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker presentation there